Guide for patients & caregivers
Positive Anti-Centromere Antibody: What Does It Mean?
A positive anti-centromere antibody explained: its link with limited systemic sclerosis (CREST) and Raynaud's, results without symptoms, and usual monitoring.
Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles
What does a positive anti-centromere antibody mean?
A positive anti-centromere antibody (ACA) result means the lab found antibodies against the centromere, a part of the cell nucleus. These antibodies are most closely linked with limited cutaneous systemic sclerosis, also called CREST syndrome, but a positive result is not a diagnosis on its own.
ACA is often first noticed as a 'centromere pattern' on an antinuclear antibody (ANA) test. Pathology Tests Explained lists scleroderma and primary biliary cholangitis, a liver condition, as the conditions linked with this pattern. A specialist interprets the result alongside your symptoms, examination and other tests.
This guide focuses on ACA specifically. For a general positive ANA, a Scl-70 result or a full ENA panel, see the related guides linked on this page.
Symptoms that need urgent care or a sooner review
Cleveland Clinic advises people with CREST syndrome to contact a provider right away for sudden chest pain, frequent dizziness or fainting, laboured breathing or blood in the stool. The NHS says to call emergency services if you have severe difficulty breathing, a tight or heavy chest, chest pain spreading to the arms, back, neck or jaw, or lips or skin turning very pale, blue or grey.
Book a sooner appointment, rather than waiting for routine follow-up, if you notice:
- Breathlessness that is new or getting worse with normal activities, or swollen ankles.
- Raynaud's attacks that are very bad or getting worse, affect only one side of the body, or come with joint pain, rashes or muscle weakness (NHS advice).
- A finger or toe that stays white, blue or dark. Cleveland Clinic notes that severe or prolonged loss of blood supply can damage tissue.
- New trouble swallowing or heartburn that will not settle.
What is limited systemic sclerosis (CREST syndrome)?
Systemic sclerosis is an autoimmune condition in which the body makes too much collagen, causing thickening and scarring. The NHS describes the limited cutaneous form as usually affecting skin on the hands, lower arms, feet, lower legs and face, although it can eventually affect the lungs and digestive system. It tends to progress gradually and is generally less severe than the diffuse form.
CREST is an acronym for five typical features, as described by Cleveland Clinic:
- Calcinosis: firm calcium deposits under the skin, often on fingertips or joints.
- Raynaud's phenomenon: fingers or toes changing colour in the cold or with stress.
- Esophageal dysmotility: reflux or swallowing difficulty because the food pipe moves less well.
- Sclerodactyly: tight, thickened skin on the fingers.
- Telangiectasias: small widened blood vessels showing as red marks on the skin.
Can you have anti-centromere antibodies without symptoms?
Yes. Some people have a positive ACA result found during tests for something else, or with Raynaud's as their only symptom. A positive result does not mean CREST syndrome is present or will definitely develop, and there is no single test that gives a yes-or-no answer for systemic sclerosis, according to Scleroderma & Raynaud's UK.
A 2025 review of systemic sclerosis antibodies explains that antibodies such as ACA can support an early diagnosis only as part of a combined assessment with nailfold capillaroscopy and clinical features. Capillaroscopy is a painless microscope check of the tiny blood vessels at the base of the nails.
Because the centromere pattern is also linked with primary biliary cholangitis, clinicians may also look at liver blood tests. The right plan depends on your whole picture, so ask your clinician what your result means for you rather than relying on general statistics.
How are Raynaud's and anti-centromere antibodies linked?
Raynaud's is common and usually not serious. The NHS notes it is often the first sign of limited cutaneous systemic sclerosis, and the 2025 review describes long-standing Raynaud's as typical of ACA-positive disease.
When someone has Raynaud's, doctors may check blood tests such as ANA to look for an underlying cause. Scleroderma & Raynaud's UK explains that assessing possible systemic sclerosis may involve seeing a specialist, usually a rheumatologist, who looks at symptoms, examination and blood tests together. The NHS recommends seeing a GP if Raynaud's starts for the first time after age 30. Keeping hands and feet warm and not smoking are standard self-care steps.
What monitoring is usually done?
Monitoring depends on whether a condition has been diagnosed. If you only have the antibody, the specialist may suggest periodic reviews to look for new features. If limited systemic sclerosis is diagnosed, the NHS says regular blood pressure checks and other tests are needed to look for organ problems.
The 2025 review links ACA with a higher risk of pulmonary arterial hypertension, raised pressure in the lung arteries, especially after several years of disease, and with a lower risk of lung scarring than Scl-70. It describes annual screening for pulmonary hypertension, often based on an echocardiogram, and baseline lung function tests and chest CT. Exact tests and timing vary between services. Treatment, when needed, aims to relieve symptoms, prevent the condition getting worse and detect complications such as pulmonary hypertension early, as the NHS describes.
Questions to ask your clinician
These questions can help you understand the result and the plan:
- Was ACA found as an ANA pattern, a specific antibody test, or both, and how strong was it?
- Do my symptoms or examination fit limited systemic sclerosis, or is this an isolated result?
- Should I have a nailfold capillaroscopy or a rheumatology referral, and how soon?
- Do my liver blood tests need checking because of the link with primary biliary cholangitis?
- If I am diagnosed, how will my heart, lungs and blood pressure be monitored, and how often?
- Which new symptoms should make me contact the team before my next appointment?
How comparing similar cases on SameCase can help
On SameCase, patients and verified doctors share de-identified cases. Reading how other people with a positive anti-centromere antibody were assessed, which follow-up tests they had and what their doctors asked can help you write a clearer list of questions for your appointment.
Other people's cases cannot tell you whether you have systemic sclerosis or how your health will change. Use them to prepare, and let your own care team interpret your results.
Sources and further reading
- NHS: Scleroderma, including limited cutaneous systemic sclerosis (reviewed March 2023)
- NHS: Raynaud's, when to see a GP (reviewed July 2023)
- Cleveland Clinic: CREST syndrome (updated November 2025)
- Frontiers in Immunology (2025, CC BY): Clinical utility of autoantibodies in systemic sclerosis
- Pathology Tests Explained (AACB): Antinuclear antibodies and ANA patterns
- Scleroderma & Raynaud's UK: Systemic sclerosis diagnosis tests
- NHS: Shortness of breath, when to call 999 (reviewed January 2024)
For patients & caregivers
Share your case and learn from others
Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.